96432 ⎘
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom; Purine radicals with ribosyl as the saccharide radical
ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS
#2ADENOSINE DERIVATIVES FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS AND CANCER
#3MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF
#4COMPOUNDS AND METHODS FOR MODULATION OF G-PROTEIN-COUPLED RECEPTORS
#5SARS-COV-2 NSP14 METHYLTRANSFERASE INHIBITORS
#6MONOMERS AND METHODS FOR SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES
#7DIAGNOSTICS FOR DETECTING ECTO-5'-NUCLEOTIDASE (CD73)
#8PROCESS FOR PREPARING NAMODENOSON
#9CYCLOPENTYL ADENOSINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
#10PYRAZINAMIDE COMPOUNDS
#11NUCLEOSIDES FOR TREATING CANCER
#12SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION
#13METHOD FOR PRODUCING 2'-MODIFIED GUANOSINE COMPOUND
#14DOUBLE-STRANDED RNA HAVING NUCLEOTIDE ANALOG
#15ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS
#16SMALL MOLECULES FOR DOT1L DEGRADATION AND USES THEREOF
#17S- AND SE- ADENOSYL-L-METHIONINE ANALOGUES WITH ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES ON TARGET BIOMOLECULES
#18SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION
#19HETEROLOGOUS PRODUCTION OF CYTOKININS IN YEASTS
#20ANTIVIRAL COMPOUNDS, METHODS FOR THE MANUFACTURING OF COMPOUNDS, ANTIVIRAL PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR THE ORAL TREATMENT OF CORONAVIRUS INFECTION AND RELATED DISEASES THEREOF
#21PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#22ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF
#23ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF
#24NOVEL NUCLEOSIDE ANALOGS AND USE THEREOF IN THERAPEUTIC TREATMENT
#25SYNTHESIS OF OLIGONUCLEOTIDES AND RELATED COMPOUNDS
#26Synthesis of 2′ protected nucleosides
#27Synthesis of 1,2,5-tri-o-benzoyl-3-dibenzylamino-3-deoxyribose as intermediate for producing 3′-amino-3′-deoxyadenosine and 3′-amino-3′-deoxyguanosine and the protected derivatives thereof
#28BRIDGED NUCLEOSIDE AND NUCLEOTIDE
#29Spirobicyclic analogues
#30MODIFIED DNA-ENCODED CHEMICAL LIBRARY AND METHODS RELATED THERETO
#31NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA
#32MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF
#33Adenosine analogs as methyltransferase inhibitors for treating cancer
#34Ectonucleotidase inhibitors and methods of use thereof
#35ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF
#366-HYDRAZINOADENOSINE COMPOUNDS WITH A2A ADENOSINE RECEPTOR AGONIST ACTIVITY
#37ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF
#38LIGAND-2'-MODIFIED NUCLEIC ACIDS, SYNTHESIS THEREOF AND INTERMEDIATE COMPOUNDS THEREOF
#39INHIBITORS OF ADENYLATE-FORMING ENZYME MENE
#40CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS
#41Spirobicyclic analogues
#42Methods of synthesizing substituted purine compounds
#43PRMT5 inhibitors
#44Production method for guanosine derivative having fluorine atom-containing functional group at position 8 and application thereof
#45Pharmaceutical agents, compositions, and methods relating thereto
#46Methods of synthesizing substituted purine compounds
#47TCO conjugates and methods for delivery of therapeutic agents
#48MODIFIED OLIGONUCLEOTIDES AND METHODS FOR THEIR SYNTHESIS
#49Adenosine analogs as methyltransferase inhibitors for treating cancer
#50Spirobicyclic analogues
#51Method for synthesizing ribonucleic acid H-phosphonate monomer, and oligonucleotide synthesis in which said monomer is used
#52Cyclic peroxides as prodrugs for selective delivery of agents
#53Ectonucleotidase inhibitors and methods of use thereof
#54Class A GPCR-binding compound modifier
#553′ end caps, 5′ end caps and combinations thereof for therapeutic RNA
#56SALT OF (SS)-ADENOSYL METHIONINE WITH INOSITOL HEXAPHOSPHATE, AND PROCESS FOR THE PREPARATION THEREOF
#57Pharmaceutical agents, compositions, and methods relating thereto
#58NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#59Process of making regadenoson and novel polymorphs thereof
#60Ectonucleotidase inhibitors and methods of use thereof
#61Methods of synthesizing substituted purine compounds
#62Cyclic peroxides as prodrugs for selective delivery of agents
#63Adenosine analogs as methyltransferase inhibitors for treating cancer
#64ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
#65HPPK inhibitors useful as antibacterial agents
#66Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
#67Method for liquid-phase synthesis of nucleic acid
#68TCO conjugates and methods for delivery of therapeutic agents
#69Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#70Linkage modified oligomeric compounds
#71COFACTOR ANALOGS AS METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER
#72Oligonucleotide production method, and nucleoside, nucleotide, or oligonucleotide
#73NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#74Ectonucleotidase inhibitors and methods of use thereof
#75Protected monomer and method of final deprotection for RNA synthesis
#76METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
#77Method for producing glycoside compounds
#783′ end caps, 5′ end caps and combinations thereof for therapeutic RNA
#79Adenosine receptor activation reagent and the uses of thereof
#80Modified oligonucleotides and methods for their synthesis
#81Oligonucleotide having non-natural nucleotide at 5′-terminal thereof
#82Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
#83Cofactor analogues for methyltransferases
#84Alternative nucleic acid molecules and uses thereof
#85TCO conjugates and methods for delivery of therapeutic agents
#86TCO conjugates and methods for delivery of therapeutic agents
#87Linkage modified oligomeric compounds
#88Dithiolane functionalized nucleoside amidites and supports for stronger immobilization of bio-molecules on solid surfaces
#89Crystal form of regadenoson and preparation method thereof
#90Cyclic peroxides as prodrugs for selective delivery of agents
#91Universal methylation profiling methods
#92RNA monomers containing 0-acetal levulinyl ester groups and their use in RNA microarrays
#93Process for the preparation of regadenoson
#94Bioconjugates of heterocyclic compounds
#95Methods of synthesizing substituted purine compounds
#96Compounds for use in prevention and treatment of neurodegenerative diseases and pain
#974′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication
#98Polynucleotide molecules and uses thereof
#99Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#100Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid
#101Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient
#102Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-YL)-3,4-dihydroxytetrahydrofuran-2-YL)] methyl nitrate and processes of preparation thereof
#103Polymorph of regadenoson
#104Ras inhibitors and uses thereof
#105Substituted nucleosides, nucleotides and analogs thereof
#106Stable solid forms of regadenoson
#107Cell-penetrating oligonucleotides
#108Protected monomer and method of final deprotection for RNA synthesis
#109Dual-action compounds targeting adenosine Areceptor and adenosine transporter for prevention and treatment of neurodegenerative diseases
#110Process for the preparation of (1-{9-[(4S, 2R, 3R, 5R)-3, 4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl}pyrazole-4-yl)-N-methylcarboxamide
#111Stable indole-3-propionate salts of S-adenosyl-L-methionine
#112Method for liquid-phase synthesis of nucleic acid
#113Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites and oligonucleotides
#114RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end
#115Linked purine pterin HPPK inhibitors useful as antibacterial agents
#116Azido nucleosides and nucleotide analogs
#117Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#118Method of reducing intraocular pressure in humans
#119Polymorph of 2-[4-[(methylamino)carbonyl]-1-pyrazol-1-yl]adenosine
#120Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient
#121Antimicrobial compounds
#122Process for preparing an A2A-adenosine receptor agonist and its polymorphs
#123Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid
#124Family of analogues and NADP+ or NADPH, their preparation and their application in therapeutics
#125Ticagrelor co-crystal
#126Processes for the preparation of regadenoson and a new crystalline form thereof
#127Synthesis of deuterated ribo nucleosides N-protected phosphoramidites, and oligonucleotides
#128Method of reducing intraocular pressure in humans
#1291,2,3-Triazolyl purine derivatives
#130Ribofuranosyl purine compounds, methods for preparing the same and use thereof
#131Antibacterial compounds
#132Modulators of histone methyltransferase, and methods of use thereof
#133External preparation for skin
#1342'-O-modified RNA
#135Method of isolating purified RNA with reduced DNA contaminations
#136Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
#137Method for oxidizing alcohols
#138Linked purine pterin HPPK inhibitors useful as antibacterial agents
#139Crystal Forms of 2--Adenosine
#140Nucleotide and/or oligonucleotide and preparation process thereof
#141Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#142RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end
#143RNA including nucleoside compound, method for regulating amount of protein produced from the RNA, and nucleoside compound
#144N-substituted adenosine derivatives and N-substituted adenine derivatives and uses thereof
#145Substitution derivatives of N-benzyladenosine-5′-monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparations containing these compounds
#146Hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells
#147Synthesis of purine nucleosides
#148Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases
#149Protected monomer and method of final deprotection for RNA synthesis
#150Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
#151Compounds and pharmaceutical compositions for the treatment of viral infections
#152Methods for transdifferentiation of body tissues
#153PROTECTED MONOMERS AND METHODS OF DEPROTECTION FOR RNA SYNTHESIS
#154RNA monomers containing O-acetal levulinyl ester groups and their use in RNA microarrays
#155Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide
#1562,1,3-BENZOXADIAZOL DERIVATIVES FOR THE INHIBITION OF INFLUENZA A AND B VIRUS AND RESPIRATORY SYNCYTIAL VIRUS REPLICATION
#157Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives
#158Azido nucleosides and nucleotide analogs
#159SUBSTITUTED NUCLEOTIDE ANALOGS
#160Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat
#161Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
#162Preparation of 2-chloro-9-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl)-adenine
#163Complex and method for enhancing nuclear delivery
#164Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference
#165Modified nucleotides
#166Process for preparing an A2A-adenosine receptor agonist and its polymorphs
#167Method of reducing intraocular pressure in humans
#168Method for preparing oligonucleotide
#169LOCKED AND UNLOCKED 2'-O PHOSPHORAMIDITE NUCLEOSIDES, PROCESS OF PREPARATION THEREOF AND OLIGOMERS COMPRISING THE NUCLEOSIDES
#170Protective group for synthesis of RNA and derivative
#171Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA
#1722-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY
#173METHOD FOR TRANSDIFFERENTIATION OF BODY TISSUES
#174Purine derivatives and methods of use thereof
#175DEUTERIUM-ENRICHED NELARABINE
#176CRYSTAL FORMS OF 2--ADENOSINE
#177Inosine derivatives and production methods therefor
#178Drug Transfer into Living Cells
#1792′-hydroxy-protected ribonucleoside derivative and production method thereof
#1805′,-substituted adenosynes preparation thereof and use as inhibitors of S-adenosylmethionine decarboxylase
#181Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as AR agonists
#182Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as AR agonists
#183CRYSTAL FORMS OF 2-[2-(4-CHLOROPHENYL)ETHOXY]ADENOSINE
#184RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end
#185Synthesis of purine nucleosides
#186Preparation of nucleotide oligomer
#187Process for preparing an A-adenosine receptor agonist and its polymorphs
#188SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGS
#189Purine nucleoside derivative modified in 8-position and medical use thereof
#190Method for identifying Smk box riboswitch modulating compounds
#191METHOD FOR TRANSDIFFERENTIATION OF BODY TISSUES
#192Process for preparing an A2A-adenosine receptor agonist and its polymorphs
#193Convertible nucleoside derivatives
#194Method of stabilizing S-adenosyl-L-methionine and stabilized composition
#195THERAPEUTIC AGENT FOR GLAUCOMA CONTAINING ADENOSINE DERIVATIVE AS ACTIVE INGREDIENT
#196Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides
#197PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS
#1982′-hydroxyl group-modified ribonucleoside derivatives
#199Process for production of crystal of purine nucleoside compound
#200COMPOUND HAVING INHIBITORY ACTIVITY ON A RHO-GTPASE CELL PROTEIN, A PROCESS FOR OBTAINING THE SAME, PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF AND A METHOD FOR THE TREATMENT OF RHO-GTPASE CELL PROTEIN-MEDIATED CONDITION
#201Oligonucleotides comprising a non-phosphate backbone linkage
#202METHOD FOR REMOVAL OF NUCLEIC ACID-PROTECTING GROUP
#203Nucleosides with antiviral and anticancer activity
#204Method for introducing a nucleic-acid protecting group
#205Oligonucleotides comprising a non-phosphate backbone linkage
#206Method for the preparation of 2-halo-2′-deoxyadenosine compounds from 2′-deoxyguanosine
#207ESTERASES FOR MONITORING PROTEIN BIOSYNTHESIS IN VITRO
#2082-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity
#209Compounds, methods, complexes, apparatuses and uses relating to stabile forms of NAD/NADH
#210Therapeutic agent for neurodegenerative disease
#211Method of producing S-adenosyl-L-methionine-containing dry yeast having excellent storage stability, the product thereof and composition for oral intake
#212Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as AR agonists
#213Deuterium-enriched nelarabine
#214Purine derivatives as adenosine Areceptor agonists and methods of use thereof
#215PHARMACEUTICAL COMPOSITIONS OF SILICON-CONTAINING SUBSTITUTED ADENOSINE NUCLEOSIDE AMIDE ANALOGS
#216Nucleoside derivatives for treating hepatitis C virus infection
#217Synthesis of 2-Substituted Adenosines
#218Organic Compounds
#219Reagents for the improved synthesis of isoguanosine containing oligonucleotides
#220Adenosine Analogs Useful as Anti-Bacterial and Anti Protozoan Agents
#221Therapeutic compounds
#222Artificial RNAóS modified at the 2ó-hydroxyl group
#223Phosphoramidite compound and method for producing oligo-RNA
#224Process for preparing an A-adenosine receptor agonist and its polymorphs
#225Process for preparing an A-adenosine receptor agonist and its polymorphs
#226Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
#227Purinenucleoside derivative modified in 8-position and medical use thereof
#228Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound
#229METHOD FOR TRANSDIFFERENTIATION OF BODY TISSUES
#230Selective O-acylation of nucleosides
#231Method for the preparation of 2-halo-2′-deoxyadenosine compounds from 2′-deoxyguanosine
#232Sugar modified nucleosides as viral replication inhibitors
#233Compounds, methods, complexes, apparatuses and uses relating to stabile forms of NAD/NADH
#234Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
#235Oligonucleotides comprising a non-phosphate backbone linkage
#236Nucleoside derivatives for treating Hepatitis C virus infection
#237Guanosine derivatives and use thereof
#238Fluorous oligonucleotide reagents and affinity purification of oligonucleotides
#239Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
#240Purine Derivatives and methods of use thereof
#2414'-thionucleotide
#242Inosine derivatives and production methods therefor
#2432-propynyl adenosine analogs with modified 5′-ribose groups having Aagonist activity
#244Method for deuteration of a heterocyclic ring
#245Processes for production of nucleosides
#246Purine Derivatives as adenosine Areceptor agonists and methods of use thereof
#247Purine nucleosides
#248Nucleoside derivatives for treating hepatitis C virus infection